A Cox hazard analysis was performed for the interval between curative treatment for HCC, total number of treatments, palliative treatment prior to DAA, total bilirubin at SVR12, AFP at SVR12, total cholesterol at SVR12, and ALBI score at SVR12. This evidence concerns the gene AFP and hepatocellular carcinoma.